Turton S, Hawkins P, Muller-Pollard C, Zois E, Conrod P, Zelaya F
Psychopharmacology (Berl). 2025; .
PMID: 40053107
DOI: 10.1007/s00213-025-06753-7.
Klausen M, Knudsen G, Vilsboll T, Fink-Jensen A
Basic Clin Pharmacol Toxicol. 2025; 136(3):e70004.
PMID: 39891507
PMC: 11786240.
DOI: 10.1111/bcpt.70004.
Huang Q, Hu B, Zhang P, Yuan Y, Yue S, Chen X
Mol Cancer. 2025; 24(1):24.
PMID: 39825376
PMC: 11740516.
DOI: 10.1186/s12943-024-02219-0.
Klausen M, Kuzey T, Pedersen J, Justesen S, Rasmussen L, Knorr U
BMJ Open. 2025; 15(1):e086454.
PMID: 39779270
PMC: 11749217.
DOI: 10.1136/bmjopen-2024-086454.
Pulido-Saavedra A, Borelli A, Kitaneh R, Alrafayia M, Jalilian-Khave L, Funaro M
Expert Opin Pharmacother. 2024; 26(2):133-146.
PMID: 39708346
PMC: 11786980.
DOI: 10.1080/14656566.2024.2446623.
In-situ oxidative polymerization of dopamine triggered by CuO in acidic condition and application in "turn-off" sensing.
Huang Y, Wu S, Yang S, He M, Ma W, Fa H
Mikrochim Acta. 2024; 191(12):760.
PMID: 39586875
DOI: 10.1007/s00604-024-06791-6.
Cannabis use disorder: from neurobiology to treatment.
Le Foll B, Tang V, Rueda S, Trick L, Boileau I
J Clin Invest. 2024; 134(20).
PMID: 39403927
PMC: 11473150.
DOI: 10.1172/JCI172887.
Genomic Study of Taste Perception Genes in African Americans Reveals SNPs Linked to Alzheimer's Disease.
Joseph P, Abbas M, Goodney G, Diallo A, Gaye A
bioRxiv. 2024; .
PMID: 39372803
PMC: 11451608.
DOI: 10.1101/2024.08.10.607452.
LEAP2, a ghrelin receptor inverse agonist, and its effect on alcohol-related responses in rodents.
Tufvesson-Alm M, Aranas C, Blid Skoldheden S, Vestlund J, Edvardsson C, Jerlhag E
Transl Psychiatry. 2024; 14(1):401.
PMID: 39358354
PMC: 11446955.
DOI: 10.1038/s41398-024-03136-y.
Genomic study of taste perception genes in African Americans reveals SNPs linked to Alzheimer's disease.
Joseph P, Abbas M, Goodney G, Diallo A, Gaye A
Sci Rep. 2024; 14(1):21560.
PMID: 39284855
PMC: 11405524.
DOI: 10.1038/s41598-024-71669-9.
Adult rat ultrasonic vocalizations and reward: Effects of propranolol and repeated cocaine administration.
Erden L, Sundarakrishnan A, Clarke P
J Psychopharmacol. 2024; 38(11):1025-1041.
PMID: 39129423
PMC: 11528876.
DOI: 10.1177/02698811241268894.
The Incentive-Sensitization Theory of Addiction 30 Years On.
Robinson T, Berridge K
Annu Rev Psychol. 2024; 76(1):29-58.
PMID: 39094061
PMC: 11773642.
DOI: 10.1146/annurev-psych-011624-024031.
Presynaptic and Postsynaptic Mesolimbic Dopamine D Receptors Play Distinct Roles in Cocaine Versus Opioid Reward in Mice.
Xi Z, Bocarsly M, Galaj E, Hempel B, Teresi C, Shaw M
Biol Psychiatry. 2024; 96(9):752-765.
PMID: 38838841
PMC: 11446657.
DOI: 10.1016/j.biopsych.2024.05.020.
Dopamine Pharmacodynamics: New Insights.
Lauretani F, Giallauria F, Testa C, Zinni C, Lorenzi B, Zucchini I
Int J Mol Sci. 2024; 25(10).
PMID: 38791331
PMC: 11121567.
DOI: 10.3390/ijms25105293.
Neural pathways for reward and relief promote fentanyl addiction.
Heilig M, Petrella M
Nature. 2024; 630(8015):38-39.
PMID: 38778188
DOI: 10.1038/d41586-024-01361-5.
Cholecystokinin neurotransmission in the central nervous system: Insights into its role in health and disease.
Asim M, Wang H, Waris A, Qianqian G, Chen X
Biofactors. 2024; 50(6):1060-1075.
PMID: 38777339
PMC: 11627476.
DOI: 10.1002/biof.2081.
Addressing cortex dysregulation in youth through brain health check coaching and prophylactic brain development.
Blum K, Braverman E, Gold M, Dennen C, Baron D, Thanos P
INNOSC Theranostics Pharmacol Sci. 2024; 7(2):1472.
PMID: 38766548
PMC: 11100020.
DOI: 10.36922/itps.1472.
Wanting-liking dissociation and altered dopaminergic functioning: Similarities between internet gaming disorder and tobacco use disorder.
Ma X, Wang M, Zhou W, Zhang Z, Ni H, Jiang A
J Behav Addict. 2024; 13(2):596-609.
PMID: 38635338
PMC: 11220823.
DOI: 10.1556/2006.2024.00011.
Epistasis in neurotransmitter receptors linked to posttraumatic stress disorder and major depressive disorder comorbidity in traumatized Chinese.
Xu L, Zhang J, Yang H, Cao C, Fang R, Liu P
Front Psychiatry. 2024; 15:1257911.
PMID: 38487579
PMC: 10937445.
DOI: 10.3389/fpsyt.2024.1257911.
The dopamine 3 receptor as a candidate biomarker and therapeutic for opioid use disorder.
Banks M, Sprague J
Addict Biol. 2024; 29(2):e13369.
PMID: 38380709
PMC: 10883601.
DOI: 10.1111/adb.13369.